Stocks with Upside Include Nvidia, Says Goldman Sachs

Nvidia stocks have 30% upside, according to Goldman Sachs
Executive Summary
Goldman Sachs says stocks like Nvidia have 30% upside, with Samsara and Ulta Beauty also on the list, offering solid execution and defensive qualities. The investment bank names several stocks that are well positioned in the current market environment. Investors looking to buy stocks with upside can consider these picks from Goldman Sachs.
Stocks with Upside Include Nvidia, Says Goldman Sachs
The stock market has been volatile in 2026, but some stocks are still offering solid upside, according to Goldman Sachs. The investment bank has named several stocks that are well positioned in the current market environment, including Nvidia, Samsara, Ulta Beauty, and Johnson & Johnson. In this article, we will explore these stocks and why Goldman Sachs thinks they have upside.
Background
The stock market has been affected by various factors, including inflation, interest rates, and global events. However, some stocks have been able to navigate these challenges and offer solid execution and defensive qualities. Goldman Sachs has identified several stocks that fit this criteria, including Nvidia, Samsara, and Ulta Beauty. These stocks have been able to perform well despite the market volatility and offer upside for investors.
Some key facts about these stocks include:
- Nvidia has a strong track record of innovation and has been able to sustain its growth profile
- Samsara has a defensible competitive moat and has been able to expand its growth drivers
- Ulta Beauty has a solid execution and has been able to gain market share
- Johnson & Johnson has a strong pharma franchise and has been able to augment its revenue growth
Key Developments
Goldman Sachs has made several key developments in its analysis of these stocks. The investment bank has:
- Reiterated its Buy rating on Nvidia, citing its improved capital allocation and commitment to balancing product innovation and ecosystem investments with shareholder returns
- Initiated coverage of Samsara with a Buy rating, citing its solid execution and defensible competitive moat
- Reiterated its Buy rating on Ulta Beauty, citing its solid execution and ability to gain market share
- Assumed coverage of Johnson & Johnson with a Buy rating, citing its strong pharma franchise and ability to augment its revenue growth
- Identified these stocks as having 30% upside, according to its estimates
Expert Analysis
Analysts at Goldman Sachs have provided expert analysis on these stocks. According to Scott Fidel, analyst at Goldman Sachs, "Nvidia's improved capital allocation should drive increased investor confidence around the company's commitment to balance product innovation and ecosystem investments with shareholder returns."
Matthew Martino, analyst at Goldman Sachs, said, "Samsara is one of the most defensible growth assets in software today, with a solid execution and expanding growth drivers."
Kate McShane, analyst at Goldman Sachs, said, "Ulta Beauty is best positioned to gain market share, with a solid execution and ability to invest in marketing, labor, and service."
Financial Impact
The financial impact of these stocks can be significant for investors. According to Goldman Sachs, these stocks have the potential to offer 30% upside, which can be a significant return on investment. Additionally, the stocks have a solid execution and defensive qualities, which can help to mitigate risk.
What This Means for India
For Indian investors, these stocks can offer a solid investment opportunity. The Indian stock market has been affected by the global market volatility, but these stocks have been able to navigate the challenges and offer upside. Indian investors can consider these stocks as part of their investment portfolio, especially those looking to invest in the US stock market.
What Happens Next
Looking ahead, these stocks are expected to continue to perform well. Goldman Sachs has reiterated its Buy rating on these stocks, citing their solid execution and defensive qualities. Additionally, the investment bank has identified these stocks as having 30% upside, which can be a significant return on investment.
In the next quarter, investors can expect to see continued growth from these stocks. Nvidia is expected to sustain its growth profile, while Samsara is expected to continue to expand its growth drivers. Ulta Beauty is expected to continue to gain market share, and Johnson & Johnson is expected to continue to augment its revenue growth.
Frequently Asked Questions
Q: What stocks does Goldman Sachs recommend buying? A: Goldman Sachs recommends buying Nvidia, Samsara, Ulta Beauty, and Johnson & Johnson, citing their solid execution and defensive qualities.
Q: Why does Goldman Sachs think these stocks have upside? A: Goldman Sachs thinks these stocks have upside because they have a solid execution and defensive qualities, which can help to mitigate risk and offer a significant return on investment.
Q: What is the potential return on investment for these stocks? A: According to Goldman Sachs, these stocks have the potential to offer 30% upside, which can be a significant return on investment.
Q: Are these stocks suitable for Indian investors? A: Yes, these stocks can be suitable for Indian investors, especially those looking to invest in the US stock market. The stocks have a solid execution and defensive qualities, which can help to mitigate risk.
Q: What happens next for these stocks? A: Looking ahead, these stocks are expected to continue to perform well, with Goldman Sachs reiterating its Buy rating and identifying them as having 30% upside.
Key Takeaways
- 30% Upside Potential: Goldman Sachs has identified these stocks as having 30% upside, which can be a significant return on investment.
- Solid Execution: These stocks have a solid execution and defensive qualities, which can help to mitigate risk.
- Growth Profile: Nvidia is expected to sustain its growth profile, while Samsara is expected to continue to expand its growth drivers.
- Market Share: Ulta Beauty is expected to continue to gain market share, and Johnson & Johnson is expected to continue to augment its revenue growth.
- Investment Opportunity: These stocks can offer a solid investment opportunity for Indian investors, especially those looking to invest in the US stock market.
Aadhya
Senior Finance CorrespondentCredentials: MS in Financial Engineering
Aadhya tracks global technology stocks, tech sector earnings, and venture capital deals in the fintech and SaaS ecosystems.
